Article
U.S. NIH starts trial for Shionogi's COVID-19 pill
Rating:
0.0
Views:
53
Likes:
1
Library:
1
The U.S. National Institutes of Health (NIH) said on Wednesday that it had started a clinical trial to evaluate Japan's Shionogi & Co Ltd's experimental oral antiviral drug to treat COVID-19.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value